Lopsided solution: On syrup-based medicines, doctor's prescription

📌 Summary:

• Context: To restore confidence in India's pharma supply chain after child deaths damaged its reputation as a drug exporter, the government has made a doctor's prescription mandatory to buy syrup-based medicines

• Mechanism: The Union Health Ministry removed the term "syrup" from Schedule K of the Drugs Rules 1945 (signalled in a Dec 2025 draft), so cough syrups can be sold only on prescription through licensed pharmacies

• Trigger: Ethylene glycol (EG) and diethylene glycol (DEG) contamination in India-made cough syrups killed over 300 children across several countries since 2022; WHO warnings in 2022 and 2023 undermined faith in India's export quality controls

• Core argument: The measure is defensive, not reformist — it addresses consumer access but NOT the real cause

• Clinical concern: Many OTC cough syrups are 'cocktails' of bronchodilators, antihistamines and decongestants → tremors, palpitations, sedation/agitation in infants; the American Academy of Pediatrics says cough suppressants are ineffective for under-6s and can mask pneumonia/asthma; India's entrenched OTC culture makes pharmacists de facto primary care providers in rural/semi-urban areas

• Root cause skipped: Contamination stemmed from failures in manufacturing quality control, raw-material testing and regulatory oversight — a prescription cannot stop contaminated products reaching the market

• Causal chain of weak enforcement: (1) government tolerates the pharma lobby's claim that high-end testing will bankrupt small manufacturers; (2) though the Indian Pharmacopoeia and Pharmacopoeia Internationalis updated methods to detect EG/DEG, batch-testing and enforcement failures persist; (3) ~3 dozen State drug controllers are chronically understaffed → without a bigger inspectorate the rule will be ignored in rural areas

• Solution implied: invest in testing infrastructure, strengthen batch testing and enforcement, expand the drug inspectorate — subpar enforcement is dangerous for a country aspiring to be the "world's pharmacy"

🎯 UPSC Relevance: GS2 — health governance, drug regulation, role of regulatory bodies; GS3 linkage to India's pharmaceutical industry and exports

📝 Prelims Facts:

• "Syrup" removed from Schedule K of the Drugs Rules, 1945

• EG/DEG contamination linked to 300+ child deaths since 2022; WHO alerts 2022 & 2023

• Indian Pharmacopoeia (IP) sets drug quality standards

🔑 Key Term: Schedule K (Drugs Rules 1945) — lists drugs/categories exempt from certain provisions of the Drugs and Cosmetics Act; removing an item tightens its sale regulation